INTERACTION OF ALUMINUM AND GALLIUM WITH HUMAN-LYMPHOCYTES - THE ROLE OF TRANSFERRIN

被引:24
作者
MCGREGOR, SJ
NAVES, ML
BIRLY, AK
RUSSELL, NH
HALLS, D
JUNOR, BJR
BROCK, JH
机构
[1] WESTERN INFIRM & ASSOCIATED HOSP, DEPT IMMUNOL, GLASGOW G11 6NT, SCOTLAND
[2] WESTERN INFIRM & ASSOCIATED HOSP, RENAL UNIT, GLASGOW G11 6NT, SCOTLAND
[3] HOSP GEN ASTURIAS, UNIDAD INVEST, OVIEDO, SPAIN
[4] CITY HOSP NOTTINGHAM, DEPT HAEMATOL, NOTTINGHAM NG5 1PD, ENGLAND
[5] GLASGOW ROYAL INFIRM, DEPT PATHOL BIOCHEM, GLASGOW G4 0SF, SCOTLAND
关键词
ALUMINUM; GALLIUM; HEMODIALYSIS; (LYMPHOCYTE);
D O I
10.1016/0167-4889(91)90099-J
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aluminium-transferrin (Al-Tf) and gallium-transferrin caused a dose-dependent decrease in proliferation of human peripheral blood lymphocytes cultured for 3 days with phytohaemagglutinin (PHA). Addition of apotransferrin reduced the inhibitory effect. Al added as AlCl3 or aluminium citrate had no effect, and there was no significant difference in the response of cells from renal failure patients with or without high serum Al levels or controls. Lymphocytes cultured in the presence of Al-Tf showed a dose-dependent uptake of Al, whereas uptake from aluminum citrate was low and not dose-dependent. Uptake from AlCl3 was very high but probably involved a nonspecific uptake mechanism. Levels of Al in freshly isolated lymphocytes were approximately 1.6 ng/10(6) cells, there being no difference between cells from patients and controls. It is concluded that Al, when bound to transferrin, may have a detrimental effect on lymphocyte function and might contribute to the decreased immune responsiveness of renal failure patients on haemodialysis. However, lymphocyte Al levels are probably not useful as a marker of Al overload in such patients.
引用
收藏
页码:196 / 200
页数:5
相关论文
共 15 条
[1]   ALUMINUM INDUCED ANEMIA - PATHOGENESIS AND TREATMENT IN PATIENTS ON CHRONIC-HEMODIALYSIS [J].
BIA, MJ ;
COOPER, K ;
SCHNALL, S ;
DUFFY, T ;
HENDLER, E ;
MALLUCHE, H ;
SOLOMON, L .
KIDNEY INTERNATIONAL, 1989, 36 (05) :852-858
[2]  
BROCK JH, 1986, IMMUNOLOGY, V57, P105
[3]   THE ROLE OF IRON AND TRANSFERRIN IN LYMPHOCYTE-TRANSFORMATION [J].
BROCK, JH ;
MAINOUFOWLER, T .
IMMUNOLOGY TODAY, 1983, 4 (12) :347-351
[4]   ROLE OF IRON-METABOLISM IN ABSORPTION AND CELLULAR UPTAKE OF ALUMINUM [J].
CANNATA, JB ;
FERNANDEZSOTO, I ;
FERNANDEZMENENDEZ, MJ ;
FERNANDEZMARTIN, JL ;
MCGREGOR, SJ ;
BROCK, JH ;
HALLS, D .
KIDNEY INTERNATIONAL, 1991, 39 (04) :799-803
[5]  
CHARPENTIER B, 1983, CLIN NEPHROL, V19, P288
[6]  
CHITAMBAR CR, 1987, BLOOD, V69, P144
[7]  
CHITAMBAR CR, 1989, CANCER RES, V49, P1125
[8]   THE BIOLOGY OF TRANSFERRIN [J].
DEJONG, G ;
VANDIJK, JP ;
VANEIJK, HG .
CLINICA CHIMICA ACTA, 1990, 190 (1-2) :1-46
[9]  
GRAHAM G, 1976, J LAB CLIN MED, V88, P477
[10]  
IHLE BU, 1986, KIDNEY INT, V518, P80